Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Time is Ripe For Large-Scale German Hospital Reform – Health Ministry

Executive Summary

DRGs are not doing what they were conceived to, ambulatory care needs more support and health care delivery across the country must be unburdened from bureaucracy, health minister Karl Lauterbach told the German hospital congress meeting during Medica 2022.

You may also be interested in...

Germany’s DRG Reform Must Retain Incentives For Medtech Innovation, Says Industry

German health ministry plans to change how inpatient care is paid for and increase levels of ambulatory care have ignited a debate among industry and other stakeholders. The medtech industry gave its initial reaction to Medtech Insight.

German Medtechs Say MDR Ball Is In EU’s Court, Plus DRG Changes and ESG Reactions

Marc-Pierre Möll, CEO of German medtech-industry association BVMed, is hoping for a more collaborative year in 2023 after the health ministry came out with proposals to change the DRGs system and the EU finally conceded that its unhelpful MDR timetable was riding roughshod over the wellbeing of patients.

German Industry Demands More Thinking Time On Hybrid DRGs

The three-way German coalition that emerged from the 2021 general election has been steadily developing elements of its coalition agreement. A proposal on hybrid DRGs, intended to widen access to services in the outpatient sector, has prompted a white paper from industry.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts